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http://dxObjective: Self-testing to determine the international normalized ratio improves management with warfarin and
reduces the risks of adverse events. Self-testing usually begins several weeks after hospital dismissal after valve
replacement. We aimed to compare the in-hospital initiation of international normalized ratio self-testing with
usual care in mechanical heart valve recipients.
Methods: A total of 200 adult mechanical heart valve recipients were randomly assigned to in-hospital interna-
tional normalized ratio self-testing instruction or usual care. Instruction for self-testing patients began on the
fourth postoperative day. The patients were followed up for 3 months to compare the number of international
normalized ratio tests, percentage of time in the therapeutic range, and adverse events.
Results: The baseline characteristics were similar between the 2 groups. During the first 3 postoperativemonths,
the usual-care group underwent an average of 10 international normalized ratio tests, and the self-testing group
completed 14 international normalized ratio tests. The mean SD percentage of international normalized ratio
tests within the therapeutic range was 45% 22% for the usual-care group and 52% 22% for the self-testing
group (P¼ .05). Within 90 days after dismissal, transient ischemic attack occurred in 1 patient in the usual-care
group and 2 patients in the self-testing group. Bleeding complications occurred in 3 patients in the usual-care
group and 5 patients in the self-testing group.
Conclusions: Management of anticoagulation with warfarin after mechanical valve replacement is improved
with self-testing, even during the early postoperative phase when international normalized ratio testing is per-
formed frequently. Although the incidence of adverse events was similar in the 2 groups, better control of the
international normalized ratio would be expected to improve outcome in large populations of patients. (J Thorac
Cardiovasc Surg 2013;146:599-604)A
C
DPatients who actively participate in their health mainte-
nance have improved clinical outcomes associated with
chronic oral anticoagulation. The risk of bleeding after
heart valve replacement is directly proportional to the inten-
sity of the anticoagulant therapy1 and the amount of time
the international normalized ratio (INR) is greater than
the therapeutic target range.2 Allowing patients to self-test
increases the number of INR measurements, which im-
proves the amount of time their INR is within the therapeu-
tic range.3 Previous studies have shown that monitoring
chronic anticoagulation in this fashion decreases thrombo-
embolic and hemorrhagic complications4,5 and improves
survival6 after mechanical heart valve replacement.
The first few months after heart valve replacement carry
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The Journal of Thoracic and Cain the INR that can result from acclimation to adjusted-
dose medication and changes in activity and diet.7-10
Also, the INR results might be inconsistent because of
testing at different laboratories.11 However, INR self-
testing is not routinely offered in many areas. Also, when
available, initiation is often deferred for several weeks after
hospital dismissal, and education can require 1 month to
complete.12
We have previously showed that inpatient INR self-
testing instruction in the immediate postoperative period
is feasible.13 The aim of the present study was to compare
the outcomes of patients with mechanical heart valves
who initiated INR self-testing in the hospital and continued
self-testing after dismissal versus the outcomes of patients
who received oral anticoagulation monitored by a physician
in the usual manner. We hypothesized that early adoption of
INR self-testing after mechanical heart valve replacement
would increase the number of INR tests performed and,
therefore, improve the percentage of time the INR was
within the therapeutic range. Also, we monitored adverse
events, including thromboembolism and bleeding.
METHODS
We studied 200 patients who had mechanical heart valve prostheses im-
planted at Mayo Clinic (Rochester, Minn) from June 2007 to January 2009.rdiovascular Surgery c Volume 146, Number 3 599
Abbreviation and Acronym
INR ¼ international normalized ratio
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DDuring the study period, 1384 adult patients (>17 years) underwent valve
replacement, and 421 (30%) of these had mechanical valves inserted. The
only exclusion criteria were disabilities or poor English language skills that
would preclude instruction and education for self-testing. TheMayo Clinic
institutional review board approved the protocol, which was registered at
ClinicalTrials.gov (identifier NCT00703963). All patients provided written
informed consent.
After enrollment, the patients were randomly assigned to a self-testing
group or a usual-care group. We had previously developed a structured
education program for early postoperative INR self-testing.13 The 4 com-
ponents of the educational program include an overview of INR self-
testing and the coagulometer and the proper methods for sampling using
a finger stick, the use of the coagulometer, and recording the test results.
The INRatio coagulometer (HemoSense, San Jose, Calif), a US Food and
Drug Administration–approved diagnostic point-of-care system, was pro-
vided to each patient in the self-testing group.
At our clinic, all recipients of the mechanical heart valves receive for-
mal education on warfarin anticoagulation, which includes an instructional
class, a video, and an informational booklet. This usual-care education was
provided to patients in both groups. For the self-testing group, INR testing
instruction was initiated as soon after surgery as the patients’ clinical status
allowed and was completed before hospital dismissal.
The protocol for anticoagulation after mechanical valve implantation
includes the use of unfractionated heparin infusion, beginning either the
night of the first postoperative day or the morning of the second postoper-
ative day. Patients continued to receive heparin until the INRwas within the
goal therapeutic range. Warfarin therapy was begun the first postoperative
day, and the goal INR therapeutic range was set in accordance with estab-
lished guidelines.14
All patients were followed up for 3 months after dismissal. Once the pa-
tients were discharged from the hospital, decisions about the dosing of war-
farin were made by the patients’ primary physicians. The self-testing
patients were instructed to perform a self-test once a week, even if a test
had not been ordered by their primary physician. To keep a record of their
INR values, the patients of both groups used the telephone to access and
then input their INR values into a Health Insurance Portability and Ac-
countability Act–compliant automated computer system. In addition, the
patients of both groups kept a written record of each INR result. The
INR values of the self-testing group were then transmitted automatically
by facsimile to their primary physician, and the patients would then tele-
phone their physician for warfarin dosing instructions. The need for other
INR self-tests, in addition to the standard weekly test, was at the discretion
of the primary physician. For the usual-care group, the frequency of INR
testing and alterations to the dose of warfarin were completely at the
discretion of the primary physician. Once the study was completed, the pa-
tients were asked to complete a study-specific survey.Statistical Analysis
The power for our study was calculated by anticipating a 10% differ-
ence between the groups in the percentage of tests within the therapeutic
range, with a standard deviation of 25%. Using a 2-sample t test, 82 pa-
tients per group provided 90% power to detect the difference. To allow
for possible patient withdrawals, the sample size was set at 100 patients
per group.
The categorical variables are reported as numbers and percentages.
Continuous variables are reported as the mean  SD or medians and
ranges. The total time a patient spent within the therapeutic range was
calculated by summing the time within the therapeutic range between600 The Journal of Thoracic and Cardiovascular Surg2 adjacent tests. The baseline categorical variables were compared between
the self-test and usual-care groups using the c2 test. The baseline continu-
ous variables, percentage of INR tests within the therapeutic range, and per-
centage of timewithin the therapeutic rangewere compared using 2-sample
t tests or the Wilcoxon rank sum test. All tests were 2-sided, and the alpha
level was set at .05 for statistical significance.
Financial support for a dedicated study coordinator was provided by
Sorin Group (Milan, Italy). The design of the study; collection, analysis,
and interpretation of the data; writing of the report; and making the deci-
sion to submit for publication were in no way influenced by Sorin Group.RESULTS
The flow of patients through the study is shown in
Figure 1. From June 2007 until January 2009, 302 consec-
utive patients were offered enrollment in the study, and
200 agreed to participate. Of the 102 patients who declined,
59 (58%) were not interested in participating, 32 (31%)
were more comfortable having their INR tested by a labora-
tory or in a physician’s office, 10 (9%) were ‘‘over-
whelmed’’ by the circumstances surrounding their cardiac
operation, and 1 patient already used self-testing for INR
management and did not want to risk enrollment in the
usual-care group.
Random assignment of the study participants resulted in
equivalent groups of 100 patients (Table 1). The median age
was 53 years in the usual-care group and 55 years in the self-
testing group. Warfarin had been used or was currently be-
ing used by 38 of the self-testing patients and 34 of the
usual-care patients, and 1 patient in each group had had
previous experience with INR self-testing. Of the 100
self-testing patients, 13 were diabetic and used self-
testing for glycemic control. Most patients had had a single
valve replaced, most of which were in the aortic position
(Table 1). The number of patients with concomitant coro-
nary revascularization and the median length of hospital
stay were similar between the 2 groups. No mortality oc-
curred in either group during the follow-up period.
The clinical status of the patients dictated when self-
testing instruction was initiated. For most patients, self-
testing instruction began the third postoperative day. The
mean number of teaching sessions per patient was 2.6 
1.2. On average, the total amount of time spent teaching
a patient how to self-test was 59  18 minutes. Before hos-
pital dismissal, all patients in the self-testing group were
able to demonstrate their ability to use the coagulometer
and record the result. A total of 21 patients, 14 in the self-
testing group and 7 in the usual-care group, withdrew
from the study after enrollment (Figure 1).
The mean number of INR tests performed by the 86 re-
maining patients in the self-testing groupwas 14 9. In con-
trast, the 93 patients remaining in the usual-care group had
a mean of 10  6 INR tests (P< .001). For the entire 3
months, the mean percentage of INR tests within the thera-
peutic range was 52%  22% for the self-testing group
and 45%  22% for the usual-care group (P ¼ .05). Theery c September 2013
FIGURE 1. Flow chart.
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Dpercentage of INR tests within the therapeutic range im-
proved during the follow-up period for the self-testing group
but not for the usual-care group (Figure 2, A). For the entire
3 months, the mean percentage of time the patients spent
within the therapeutic range was 53%  27% for the
self-testing group and 48%  25% for the usual-care group
(P ¼ .20). When examined by month, however, the percent-
age of time spent within the therapeutic range increased for
the self-testing patients (Figure 2, B). In the third month, the
mean percentage of time the INR self-testing patients spent
within the therapeutic range was 59%  32% and that for
the usual-care group was 40%  38% (P ¼ .01).
Nine patients in the self-testing group had an adverse
event after hospital discharge (Table 2). In both patients ex-
periencing a transient ischemic attack, the INR was within
the therapeutic range, and both patients had complete reso-
lution of their symptoms. The magnetic resonance imaging
findings of these 2 patients were normal. Two patients un-
derwent chest tube thoracostomy for drainage of a hemo-
thorax. Both patients were within the therapeutic range at
the diagnosis of hemothorax. One patient was found to
have a subdural hematoma after evaluation for new onset
of severe headaches. Initially, the subdural hematoma was
managed conservatively, and her INR was kept within the
therapeutic range (2.5-3.5). The hematoma enlarged on sub-
sequent computed tomography scans, and decompressive
craniotomy was performed. Two patients had pericardial
effusion that presented as chest pain, and both patients un-
derwent a single pericardiocentesis without recurrence. One
patient had an INR of 2.5 (goal, 2-3) at presentation, and the
other had an INR of 1.9 (goal, 2-3) at presentation. OneThe Journal of Thoracic and Capatient with pulmonary embolism had a subtherapeutic
INR of 1.7 at presentation (goal, 2-3). The embolism was
treated by ensuring tighter INR control by the patient’s pri-
mary physician.
Seven patients in the usual-care group reported an ad-
verse event after hospital discharge (Table 2). Neurologic
symptoms were reported by 4 of these patients; magnetic
resonance imaging showed normal results in 3 of the 4.
An incidental right-sided cavernous malformation of the
cerebellum was noted on magnetic resonance imaging in
the fourth patient, who reported transient facial numbness
and had had a possible transient ischemic attack. The bleed-
ing risk from this malformation was considered low, and
routine anticoagulation was continued. One of these pa-
tients reported symptoms suggestive of amaurosis fugax
and was found to have a subtherapeutic INR level at the
event. Bleeding complications were reported by the remain-
ing 3 patients. One patient with a hemorrhagic pericardial
effusion returned to the hospital 4 days after discharge
with new chest pain, and the INR was found to be 8. The
INR was corrected, and the patient’s symptoms resolved
with pericardiocentesis. The other 2 patients were within
the therapeutic range when superficial bleeding occurred,
which was controlled with application of pressure.
The study-specific surveys were returned by 78 self-
testing patients and 84 usual-care patients. Of the self-
testing respondents, 64 (82%) agreed that they had
recovered enough when self-testing instruction was initi-
ated. Only 5 patients (6.4%) had not thought they were
ready to self-test at hospital discharge. At 3 months
after hospital discharge, 74 self-testing patients (95%) feltrdiovascular Surgery c Volume 146, Number 3 601
TABLE 1. Baseline demographic and operative characteristics
Characteristic
Self-testing
group (n ¼ 100)
Usual-care
group (n ¼ 100)
Age (y)
Median 55 53
Range 18-79 19-84
Men 67 60
Previous warfarin use 38 34
Hypertension 11 13
Type 1 diabetes mellitus 13 7
NYHA classification
I 24 17
II 35 36
III 33 38
IV 8 9
LVEF (%) 58.6  0.1 59.2  0.1
Previous experience with INR
self-testing
1 1
Valves replaced
Aortic 60 68
Mitral 20 17
Tricuspid 4 3
Pulmonary 1 1
Double valve 14 8
Aortic and mitral 4 4
Aortic and pulmonary 3 3
Aortic and tricuspid 3
Mitral and pulmonary 2 1
Mitral and tricuspid 1
Pulmonary and tricuspid 1
Triple valve 1 3
Aortic, mitral, and pulmonary 1
Aortic, mitral, and tricuspid 3
Concomitant coronary
revascularization
13 12
Hospital stay (d)
Median 6 6
Range 3-70 4-36
Data presented as median and range, number of patients, or mean SD. NYHA, New
York Heart Association; LVEF, left ventricular ejection fraction; INR, international
normalized ratio.
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Dexcellent or very good about self-testing their INR. In
contrast, only 52 patients (62%) in the usual-care group
were comfortable with the method by which their INR was
monitored. Only 1 self-testing patient required more than
30 minutes to complete an INR test, and 64 usual-care
patients (76.2%) reported that an INR test took 30 minutes
or more (Figure 3). Of the 84 patients in the usual-care
group, 61 (72.6%) indicated they would prefer self-testing
to having their INR determined at a medical laboratory or
doctor’s office, and 33 (39.3%) stated they would definitely
begin INR self-testing once the study was completed. De-
spite being in the self-testing group, 37 patients (47.4%)
were asked by their primary physician to have at least 1 INR
test at a conventional laboratory, in addition to self-testing.602 The Journal of Thoracic and Cardiovascular SurgDISCUSSION
The results from the present randomized controlled trial
have demonstrated that recipients of mechanical heart
valves are able to learn INR self-testing while convalescing
in the hospital. The patients are then able to initiate INR
self-testing immediately after being discharged from the
hospital. In the present study, INR self-testing was associ-
ated with more INR tests within the therapeutic range,
a greater percentage of time spent within the therapeutic
range during the third postoperative month, and no greater
rate of complications compared with the patients receiving
usual care.
Although anticoagulation monitoring using point-of-care
devices has been available for more than 20 years, it has not
been widely used in the United States. It has been estimated
that 60% of dedicated anticoagulation clinics in this coun-
try prohibit INR self-testing for enrolled patients and
that fewer than 1% of patients receiving care at anticoagu-
lation clinics use self-testing to obtain INR results.15 In
contrast, some centers in Europe have enrollment as great
as 85%,16 in part because it is viewed as more cost-effec-
tive.17 In the present study, only 2 physicians requested
that their patients not be allowed to self-test, suggesting
that many physicians in the United States would be accept-
ing of INR self-testing.
A potential barrier to implementing INR self-testing is
the cost of the education and equipment. An in-hospital pro-
gram for INR self-testing decreases the subsequent time and
cost to patients and providers for training. In July 2002, the
Centers for Medicare and Medicaid Services began cover-
age for home INR monitoring, and many insurance compa-
nies have followed suit. Although Medicare stipulates that
patients undergo an educational program on anticoagulation
management and the use of a device before its use at home,
regulations also state that patients must receive anticoagula-
tion therapy for at least 3 months before using home INR
monitoring. We believe, however, that early initiation of
self-testing is worthwhile for patients with mechanical
valves because early introduction of the technology will
increase the number of patients who ultimately use self-
testing. Furthermore, in the early postoperative period,
patients and families are attentive and able to learn manage-
ment of their heart disease and the prosthetic valve.
In the present study, patients were instructed in self-
testing, not self-management. With self-testing, the patient
uses a portable coagulometer to analyze the INR from
a drop of blood obtained by finger stick, but the healthcare
provider decides the dosing adjustments. In contrast, self-
management implies that the patient performs the blood
analysis and then decides on any dosage adjustment accord-
ing to the displayed INR value. Self-management requires
additional training and oversight that is best coordinated
by the referring cardiologist or primary physician. Weery c September 2013
FIGURE 2. International normalized ratio (INR) test results in therapeutic
range. A, Mean percentage of INR tests within therapeutic range in self-
testing group (n ¼ 86, light bars) and usual-care group (n ¼ 93, dark
bars). B, Mean percentage of time spent in therapeutic range in self-
testing group (n¼ 86, light bars) and usual-care group (n¼ 93, dark bars).
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postoperatively will later transition to self-management.
The quality of chronic oral anticoagulation management
achieved with self-testing has been shown to be equivalent
to that with self-management, and both appear to be supe-
rior to usual care.18
The number of adverse events was similar between our 2
study groups, and the adverse events often occurred even
though the INR was in the therapeutic range. However,TABLE 2. Adverse events occurring within the first 90 days after hospital
Adverse event
Self-testing group (n ¼
Patients (n) Interval after
TIA 2 7,
Possible TIA
Temporary visual change
Hemothorax 2 4,
Evacuation of subdural hematoma 1 6
Bloody pericardial effusion 2 8,
Pulmonary embolism 1 2
Bleeding after shaving
Epistaxis
Bleeding scalp 1 N
TIA, Transient ischemic attack; NA, not available. *Amaurosis fugax.
The Journal of Thoracic and Cafewer neurologic events occurred among the self-testing pa-
tients. Also, during the initial 3-month period, the number
of in-range INR tests continued to improve in the self-
testing group, but the number of in-range tests in the
usual-care group remained relatively constant. It is possible
that INR self-testing more than once per week would
further improve the time in the therapeutic range, but this
hypothesis has not yet been tested. After heart valve re-
placement with a mechanical prosthesis, the peak incidence
of thromboembolism occurs during the first 3 months,
after which the per-annum incidence of thromboembolism
remains relatively constant.7,10 This observation probably
reflects the lack of endothelialization of the newly
implanted prosthetic materials; thus, increasing the
number of INR tests within the therapeutic range early
after heart valve replacement should decrease the number
of thromboembolic events.
Even if the adverse event rates are similar between self-
testing and usual care, patients might still prefer to self-
test. It has been shown that INR self-management improves
patients’ quality of life.19,20 More INR tests were performed
in the self-testing group than in the usual-care group, which
could provide better control of the INR in large patient pop-
ulations. Performing an INR self-test a few more times
might actually be less burdensome, considering the time
needed to perform a self-test compared with the time re-
quired for a conventional INR test. Other health mainte-
nance areas have shown that decreased waiting periods,
travel time, and travel costs generate greater patient satis-
faction.15,16,21 Also, collaborating with a physician using
the telephone is particularly valued by patients in rural
areas or those whose health or social circumstances make
visits to the hospital difficult.22
The present study had several limitations. Because the
adverse event rate after mechanical heart valve implantation
is greatest early after surgery, we chose a relatively short
follow-up period. The study patients will need to be pro-
spectively observed to determine the long-term prevalence
of continued self-testing, crossing over by members of thedismissal
86) Usual-care group (n ¼ 93)
discharge (d) Patients (n) Interval after discharge (d)
14 1* 44
1 33
2 14, 18
8
0
23 1 4
1
1 NA
1 NA
A
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FIGURE 3. Typical time required to obtain international normalized ratio
(INR) result. Total time included transportation, having blood drawn, and
waiting for test results. Self-testing group (n ¼ 78) indicated by light
bars; usual-care group (n ¼ 84), dark bars.
Acquired Cardiovascular Disease Thompson et al
A
C
Dusual-care group to self-testing, and the frequency of ad-
verse events. Our study population included only adults;
however, self-testing has also proved effective in a pediatric
population.23 The present study was monocentric with ded-
icated study personnel, and similar studies are needed to
validate the results.CONCLUSIONS
The recipients of mechanical heart valves who are taught
INR self-testing before hospital dismissal are able to self-
test immediately after hospital dismissal. Early INR self-
testing promoted a greater percentage of INR tests within
the goal therapeutic range compared with usual care. Al-
though the overall number of reported adverse events was
similar, the self-testing patients had fewer neurologic
events. Most primary physicians were accepting of self-
testing, but almost one half still requested that an occasional
conventional INR test be performed, in addition to the self-
testing. Self-testing patients reported being more comfort-
able with how their INR was monitored, and the difference
in time needed to obtain an INR value using self-testing
versus usual care was striking.References
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